Age Increases Expression and Receptor-Mediated Activation of Gα i in Human Atria

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 5, 2003, Pages 662-670

  Kilts, Jason D ^a   Akazawa, Toshimasa ^a   El Moalem, Habib E ^a   Mathew, Joseph P ^a   Newman, Mark F ^a   Kwatra, Madan M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

adrenergic; Adenylyl cyclase; Cardiac; Glucagons; Muscarinic

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ALPRENOLOL; ATROPINE; AZIDOANILIDOGUANOSINE TRIPHOSPHATE P 32; BETA 2 ADRENERGIC RECEPTOR; CARBACHOL; CYANOPINDOLOL I 125; CYCLIC AMP; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GI2 ALPHA PROTEIN; GI2-ALPHA PROTEIN; GLUCAGON; GUANOSINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE DERIVATIVE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; ONCOPROTEIN; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADULT; AGE; AGED; AGING; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEART ATRIUM; HEART ATRIUM CONTRACTILITY; HEART MUSCLE; HUMAN; ISOTOPE LABELING; MALE; METABOLISM; NONPARAMETRIC TEST; PHOTOAFFINITY LABELING; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADULT; AGED; AGING; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; STATISTICS, NONPARAMETRIC;

EID: 0142200898     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200311000-00013     Document Type: Article

References (57)

1. Brodde OE, Broede A, Daul A, et al. Receptor systems in the non-failing human heart. Basic Res Cardiol. 1992;87:1-14.
2. Kelly J, O'Malley K. Adrenoceptor function and ageing. Clin Sci. 1984;66:509-515.
3. Brodde OE, Zerkowski HR, Schranz D, et al. Age-dependent changes in the β-adrenoceptor-G-protein(s)-adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol. 1995;26:20-26.
4. White M, Roden R, Minobe W, et al. Age-related changes in β-adrenergic neuroeffector systems in the human heart. Circulation. 1994;90:1225-1238.
5. Urasawa K, Murakami T, Yasuda H. Age-related alterations in adenylyl cyclase system of rat hearts. Jpn Circ J. 1991;55:676-684.
6. iα expression in senescence. Am J Physiol. 1993;264:H805-H814.
7. Ferrara N, Böhm M, Zolk O, et al. The role of Gi-proteins and β-adrenoceptors in the age-related decline of contraction in guinea-pig ventricular myocytes. J Mol Cell Cardiol. 1997;29:439-448.
8. Roth DA, White CD, Podolin DA, et al. Alterations in myocardial signal transduction due to aging and chronic dynamic exercise. J Appl Physiol. 1998;84:177-184.
9. Stratton JR, Cerqueira MD, Schwartz RS, et al. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation. 1992;86:504-512.
10. Lakatta EG. Research agenda for cardiovascular aging: humans to molecules. Am J Geriatr Cardiol. 2000;9:251-262.
11. Steinberg SF. The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res. 1999;85:1101-1111.
12. i. Circ Res. 2000;87:705-709.
13. Feldman AM, Cates AE, Veazey WB, et al. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988;82:189-197.
14. Brodde OE, Michel MC, Zerkowski HR. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res. 1995;30:570-584.
15. Johnson MD, Zhou Y, Friedman E, et al. Expression of G protein α subunits in the aging cardiovascular system. J Gerontol A Biol Sci Med Sci 1995;50A:B14-B19.
16. Shu Y, Scarpace PJ. Forskolin binding sites and G-protein immunoreactivity in rat hearts during aging. J Cardiovasc Pharmacol. 1994;23:188-193.
17. Chin JH, Hiremath AN, Hoffman BB. cAMP signaling mechanisms with aging in rats. Mech Ageing Dev. 1996;86:11-26.
18. iα-proteins in rat heart. Biochem Pharmacol. 1994;48:479-486.
19. 2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest. 1998;101:1273-1282.
20. sα protein mRNA in rat ventricular myocardium with aging. Eur J Pharmacol. 1994;266:147-154.
21. i2 expression, resulting in enhanced coupling to G protein-coupled receptors. J Biol Chem. 2002;277:31257-31262.
22. 2-adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium. Mol Cell Biochem. 1996;163/164:113-123.
23. 2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation. 1999;99:65-72.
24. s-protein. Circulation. 2000;102:1814-1821.
25. 2+ current in single rat ventricular cells. Circ Res. 1993;73:286-300.
26. 2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem. 1994;269:19151-19156.
27. 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 1995;47:322-329.
28. --dependent intracellular alkalinization. Am J Physiol. 1997;273:H1044-H1047.
29. 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:56-69.
30. 2-adrenoceptors in sheep cardiac ventricular muscle. J Mol Cell Cardiol. 1992;24:753-764.
31. 2-adrenergic stimulation. Circulation. 1995;92:1612-1618.
32. αo. FEBS Lett. 1998;428:291-294.
33. Ho KKL, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol. 1993;22(suppl A):6A-13A.
34. Feldman RD, Tan CM, Chorazyczewski J. G protein alterations in hypertension and aging. Hypertension. 1995;26:725-732.
35. 32P]GTP azidoanilide. Methods Enzymol. 1991;195:286-301.
36. Niroomand F, Mura RA, Piacentini L, et al. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:643-649.
37. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974;58:541-548.
38. 1-adrenoceptor-blocked and non-β-adrenoceptor-blocked human atrium. Clin Sci. 1995;88:571-580.
39. Feldman AM, Cates AE, Bristow MR, et al. Altered expression of α-subunits of G proteins in failing human hearts. J Mol Cell Cardiol. 1989;21:359-365.
40. iα-2 in human end-stage heart failure. Circ Res. 1992;70:688-696.
41. q/11. Mol Pharmacol. 1994;45:890-898.
42. Moss J, Bruni P, Hsia JA, et al. Pertussis toxin-catalyzed ADP-ribosylation: effects on the coupling of inhibitory receptors to the adenylate cyclase system. J Recept Res. 1984;4:459-474.
43. Wegener AD, Simmerman HKB, Lindemann JP, et al. Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to β-adrenergic stimulation. J Biol Chem. 1989;264:11468-11474.
44. Koss KL, Kranias EG. Phospholamban: a prominent regulator of myocardial contractility. Circ Res. 1996;79:1059-1063.
45. Mundiña de Weilenmann C, Vittone L, de Cingolani G, et al. Dissociation between contraction and relaxation: The possible role of phospholamban phosphorylation. Basic Res Cardiol. 1987;82:507-516.
46. Lakatta EG. Cardiovascular aging research: the next horizons. J Am Geriatr Soc. 1999;47:613-625.
47. Derweesh IH, Wheeler MA, Weiss RM. Alterations in G-proteins and β-adrenergic responsive adenylyl cyclase in rat urinary bladder during aging. J Pharmacol Exp Ther. 2000;294:969-974.
48. 1-adrenoceptor effects in ventricular myocytes from NE-treated guinea pigs. Am J Physiol Heart Circ Physiol. 2000;278:H1807-H1814.
49. iα in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 1990;82:1249-1265.
50. i-coupled receptor in transgenic mice. Nat Biotechnol. 1999;17:165-169.
51. i-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci U S A. 2000;97:4826-4831.
52. i-coupled receptor in transgenic model of dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2001;280: H1653-H1659.
53. + channel, GIRK. Neuron. 2002;33:87-99.
54. i3 proteins by basic secretagogues induces exocytosis through phospholipase Cβ and arachidonate release through phospholipase Cβ in mast cells. J Immunol. 2001;167:4805-4813.
55. Schnabel P, Gäs H, Nohr T, et al. Identification and characterization of G protein-regulated phospholipase C in human myocardium. J Mol Cell Cardiol. 1996;28:2419-2427.
56. i family members in platelets. J Biol Chem. 2002;277:23382-23390.
57. i-dependent activation of platelet Rap1B. J Biol Chem. 2003;278:131-138.